MARCKS protein overexpression is associated with poor prognosis in male breast cancer.
Authors
Manai M, Abdeljaoued S, Goucha A, Adouni O, Bettaieb I, Bouzaien H, Rahal K, Birnbaum D, Bertucci F, Gamoudi A
Summary
Male breast cancer (MBC) is a rare and aggressive disease. Thus, identification of new therapeutic targets is crucial.
Read the article